Akebia Therapeutics, Inc. (AKBA) Financials
AKBA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 349.7 million | 324.6 million |
| March 31, 2026 | 362.5 million | 335.1 million |
| Dec. 31, 2025 | 376.6 million | 344.0 million |
| Sept. 30, 2025 | 364.2 million | 322.6 million |
AKBA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 2.4 million | 3.2 million |
| March 31, 2026 | -21.2 million | 3.7 million |
| Dec. 31, 2025 | 31.0 million | 3.2 million |
| Sept. 30, 2025 | 28.0 million | 3.2 million |
AKBA Net Income
No data available :(
AKBA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 155.5 million | 24.8 million | 4.4 million |
| March 31, 2026 | 162.6 million | - | 2.1 million |
| Dec. 31, 2025 | 184.8 million | 48.3 million | 3.5 million |
| Sept. 30, 2025 | 166.4 million | 47.6 million | 4.9 million |
AKBA Shares Outstanding
AKBA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 1.1 million | 14.1 million | 28.2 million | - |
| March 31, 2026 | 62000 | 14.8 million | 30.4 million | - |
| Dec. 31, 2025 | 162000 | 26.6 million | 26.1 million | - |
| Sept. 30, 2025 | 77000 | 14.6 million | 30.0 million | - |
AKBA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 49.1 million | 10.4 million |
| March 31, 2026 | 53.5 million | 12.6 million |
| Dec. 31, 2025 | 57.6 million | 12.2 million |
| Sept. 30, 2025 | 58.8 million | 9.7 million |
AKBA Revenue by Segment
Graph available only for paid members. Upgrade to see it.
AKBA
Price: $0.80
52 week price:
Earnings Per Share: -0.12 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 1.3 million
Ebitda: -24.0 millionMarket Capitalization: 232.0 million